RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Catalyst Biosciences Stock

Catalyst Biosciences P/S 2024

Catalyst Biosciences P/S

0

Ticker

CBIO

ISIN

US14888D2080

WKN

A2DLUK

As of Jul 27, 2024, Catalyst Biosciences's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Catalyst Biosciences P/S history

Catalyst Biosciences Aktienanalyse

What does Catalyst Biosciences do?

Catalyst Biosciences Inc. is a biotechnology company specializing in the development of innovative therapies for rare diseases and severe bleeding disorders. They collaborate with doctors, academics, and patient organizations to bring new treatment options to the market. Their business model is based on the development of proteins that influence the blood clotting process to prevent or reduce bleeding. They use a proprietary technology called Protease Engineering Platform (PEP) to make customized proteins. Catalyst Biosciences Inc. focuses on therapies for rare diseases such as hemophilia A and B, hemorrhagic diathesis, and other rare diseases like factor XIII deficiency or thrombasthenia. They offer a range of products, including CB 2679d, CB 813d, and CB 2679f for the treatment of hemophilia B. Catalyst Biosciences Inc. has achieved milestones and is considered one of the most promising companies in the industry. With its innovative technology and comprehensive portfolio, it has the potential for further success. Catalyst Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Catalyst Biosciences's P/S Ratio

Catalyst Biosciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Catalyst Biosciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Catalyst Biosciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Catalyst Biosciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Catalyst Biosciences stock

What is the price-to-earnings ratio of Catalyst Biosciences?

The price-earnings ratio of Catalyst Biosciences is currently 0.

How has the price-earnings ratio of Catalyst Biosciences changed compared to last year?

The price-to-earnings ratio of Catalyst Biosciences has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Catalyst Biosciences high compared to other companies?

Yes, the price-to-earnings ratio of Catalyst Biosciences is high compared to other companies.

How does an increase in the price-earnings ratio of Catalyst Biosciences affect the company?

An increase in the price-earnings ratio of Catalyst Biosciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Catalyst Biosciences affect the company?

A decrease in the price-earnings ratio of Catalyst Biosciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Catalyst Biosciences?

Some factors that influence the price-earnings ratio of Catalyst Biosciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Catalyst Biosciences pay?

Over the past 12 months, Catalyst Biosciences paid a dividend of 1.43 USD . This corresponds to a dividend yield of about 8.01 %. For the coming 12 months, Catalyst Biosciences is expected to pay a dividend of 0.24 USD.

What is the dividend yield of Catalyst Biosciences?

The current dividend yield of Catalyst Biosciences is 8.01 %.

When does Catalyst Biosciences pay dividends?

Catalyst Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Catalyst Biosciences?

Catalyst Biosciences paid dividends every year for the past 0 years.

What is the dividend of Catalyst Biosciences?

For the upcoming 12 months, dividends amounting to 0.24 USD are expected. This corresponds to a dividend yield of 1.34 %.

In which sector is Catalyst Biosciences located?

Catalyst Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Catalyst Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Catalyst Biosciences from 1/12/2023 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2023.

When did Catalyst Biosciences pay the last dividend?

The last dividend was paid out on 1/12/2023.

What was the dividend of Catalyst Biosciences in the year 2023?

In the year 2023, Catalyst Biosciences distributed 1.43 USD as dividends.

In which currency does Catalyst Biosciences pay out the dividend?

The dividends of Catalyst Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Catalyst Biosciences

Our stock analysis for Catalyst Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalyst Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.